, M.D.,
Bernard Halpern, XX.D.andJanice Perlman, X.S.
XXXXXXXX
The XXXXXX XXX the increased incidence XXX XXXXXXXX of XXXXXXXXXX in diabetic XXXXXXXX XXX never been XXXXXXXXXXXXXX XXXXXXXXX. XXXX investigation XXX XXXXXXXX XX XXXXX the XXXXXXXXXXX antibody XXXXXXXX in XXXXXXX XXXXXXXX, insulin XXXXXXX diabetic and XXXXXX XX-1 XXXX XXXXXXXX with XXXXXX serum albumin. Only those XXXXXXX XXXXXXX with XXXXXXX XXX had XXXXXXXX XXXXX glucose levels (250 XX./100 ml. or XXXXXX) were XXXXXXXX in the XXXXX, XXXXXXXX XXXX a XXXXX of XXXXXX animals. XXXXXXX were bled from XXX XXXXXXX XXXXX and XXX serum XXXXXXXX for XXXXXXX XXXXXXX capacity of BSA, glucose concentration and serum XXXXXXXX. BSA was iodinated with I-XXX and XXX antigen XXXXXXX capacity XX XXXX XXXXX sample was determined as micrograms XX BSA nitrogen XXXXX XX X ml. of XXXXXXXXX serum. Our studies demonstrate XXXX there is XX significant difference in XXXXXXXX response XX XXXXXXX XXXXXXX XXXX, alloxan XXXXXXX mice given XXXXXXX XXX normal mice when XXXXXXXXX XXXX XXX XXXXX XXX conditions XX XXX experiments. If the XXXXXXX XXXXXXX mouse XXX XX considered a laboratory XXXXX of diabetes XXXXXXXX in XXX, the results described XXXXXX XXXXX XX XXXXXXXXXX with XXXXX studies XX XXXXXXXXX XXXXX have XXXXX no XXXXXXX XXXXXX in XXXXX immune XXXXXXX.
XXXXXXXXX © 1971 by the XXXXXXXX Diabetes XXXXXXXXXXX">